We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Ajinomoto Buys California-Based CDMO Althea Technologies

March 6, 2013: 12:00 AM EST
Ajinomoto Co., Inc., said it has agreed to acquire Althea Technologies, Inc., a biopharmaceutical contract development and manufacturing organization. Ajinomoto said the acquisition is part of its efforts to expand into the biopharmaceutical industry. Expected to close in April 2013, the deal will make Althea, a fully integrated CDMO that provides fill and finish, biologics manufacturing, analytical development, and stability testing services for biopharmaceutical companies, into a fully consolidated subsidiary Ajinomoto.
"Ajinomoto Co., Inc. agrees to acquire Althea Technologies, Inc., a U.S.-based biopharmaceutical CDMO*1 for approx. USD 175 million", Ajinomoto, March 06, 2013, © Ajinomoto Co.
North America
United States of America
Companies, Organizations
Deals, M&A, JVs, Licensing
Developed by Yuri Ingultsov Software Lab.